Skip to main content

Single cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib resistant patients

*January 2022*


  • Clonal architecture¬†of¬†molecular alterations at the cellular level depicts cancer cell adaptation during targeted therapy.
  • Single cell sequencing from patient biopsies revealed the co-existence of two driver alterations within single cancer cells.
  • Pharmacological evaluation in patient derived models asserts the need of simultaneous inhibition of each driver.

Read more.